DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the PE ratio of Smruthi Organics Ltd?

Smruthi Organics Ltd has a price-to-earnings (PE) ratio of 38.0 in the Healthcare sector.

What is the market capitalisation of Smruthi Organics Ltd?

Smruthi Organics Ltd has a market capitalisation of approximately ₹130 crore.

Smruthi Organics Ltd

540686·NSE·Healthcare

₹0.00▲ +0.00 (+0.00%)

Mkt Cap₹130 Cr

P/E38.00

Vol—

Day—

52W95–164

Trading suspended. Not a live price.

Healthcare · Pharmaceuticals

A steady, established business

O—H—L—PC—VWAP—VOL—

52W₹95.00

₹164.00

Snapshot

Key stats

Mkt Cap

₹130 Cr

P/E

38.00Expensive

P/B

1.77

ROE

5.17%Weak

ROCE

8.00%Weak

52W High / Low

₹164 / ₹95

Div Yield

1.32%

EPS

₹3.11

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

38.0Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

5.2%Weak

Above 15% is considered healthy for Indian equities

ROCE

8.0%Weak

Above 18% means capital is working hard

Debt/Eq

0.11Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹130 Cr

P/B

1.77

EPS

₹3.11

Div Yield

1.32%

What changed

Recent changes

No notable changes to report.

What matters

News impact

Today

Trading activity

Delivery %—

Turnover—

Trades—

VWAP—

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

-10.2%

-4.1%

10Y

+3.3%

Profit

-5.3%

-27.5%

10Y

+13.0%

EPS

-55.0%

-53.4%

10Y

-6.3%

Profile

Pros

Company has reduced debt.
Company has been maintaining a healthy dividend payout of 48.7%
Debtor days have improved from 93.5 to 69.1 days.

Watch-outs

Cons

The company has delivered a poor sales growth of -4.22% over past five years.
Company has a low return on equity of 5.14% over last 3 years.
Company's cost of borrowing seems high

More Healthcare stocks · Pharmaceuticals

Explore Smruthi Organics Ltd’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.